Overview
This presentation will highlight the new drugs approved in 2022 by the FDA that will be prescribed in general clinical practice. Aspects that will be reviewed for each new drug include: indications, efficacy, pharmacokinetics, safety, dosing, cost, and comparison vs. existing drugs. The material learned will be reinforced by clinically applicable cases.
Learning Objectives
- Identify the new drugs approved by the FDA that are most clinically relevant to general practice
- Discuss relevant indications, efficacy, pharmacokinetics, safety, and dosing of the new drugs
- Compare and contrast the new drugs with existing drugs on the market
- Determine how to best incorporate the new drugs into clinical practice using a case-based format
Intended Audience: Pharmacists and Pharmacy Technicians
Activity Type: Knowledge
Contact Hours: 1.5
Speakers
Mark Johnson PharmD, BCPS
Professor of Pharmacy Practice, Director of Postgraduate Education
Bernard J. Dunn School of Pharmacy, SU
Registration Rates
VPhA Member: $20
Non-Member: $35
Click Here is you are unable to view the Lecture Panda Registration below.